Johnson & Johnson

Pharmaceuticals

Company Summary

Johnson & Johnson, a global healthcare leader, has made a lot of sustainable progress by incorporating ESG principles into its operations. The company is committed to sustainable practices, including carbon neutrality and waste reduction, aiming for net-zero emissions by 2030. J&J's ESG rating reflects its positive efforts in improving healthcare access and investing in philanthropy. However, the company has faced ongoing legal and governance issues, particularly related to lawsuits concerning its talcum powder products, which have raised concerns about corporate ethics and accountability. Despite these challenges, Johnson & Johnson’s ESG score is bolstered by its contributions to global health, including COVID-19 vaccine development and its focus on diversity and inclusion. For more insights into Johnson & Johnson's ESG practices, refer to the latest Johnson & Johnson ESG report, which details the company’s progress and areas for improvement. The company has a medium ESG risk, medium exposure to material ESG issues, and a strong score in managing those issues, particularly in areas like corporate governance, human capital, business ethics, and product governance. Despite this, Johnson & Johnson has faced some controversies regarding product quality and safety. They have not yet set a decarbonisation target or specific climate goals, but their ESG strategy is aligned with long-term objectives aimed at reducing their carbon footprint. To learn more about their commitment to health and environmental sustainability, you can download the Johnson and Johnson CSR report and Health for Humanity report above. Johnson & Johnson’s sustainability initiatives focus on creating healthy communities and empowering employees to take action for a healthier world. The company is committed to a healthy planet by increasing its reliance on renewable energy sources, reducing electricity needs, and protecting natural resources. Their ESG strategy is framed by the Global Reporting Initiative (GRI) and other reporting frameworks to ensure transparency. Johnson & Johnson aims to transform healthcare and social well-being by addressing environmental and social issues. Their commitment to a healthier future is linked to their efforts in environmental protection, climate action, and improving the health of the communities they serve.

ESG Rating Overview

Sustainalytics

Overall ESG Rating :

20.1
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
Ranking
Industry Group
Pharmaceuticals87 out of 851
Universe
Global Universe4353 out of 15104

Overall ESG Rating :

85
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
0100E93S98G60

Overall ESG Rating :

A
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader

J&J is Average among 236 companies in the pharmaceuticals industry.

Temperature Rise :

1.8℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned

News from Johnson & Johnson

FAQ

What is Johnson & Johnson's ESG score?

Johnson & Johnson has an ESG score of 68/100 (according to Sustainalytics), reflecting its dedication to environmental responsibility, social impact, and strong governance practices.

How does Johnson & Johnson handle ESG issues?

What sustainability practices does Johnson & Johnson follow?